<DOC>
	<DOCNO>NCT02616146</DOCNO>
	<brief_summary>The purpose study assess contraceptive efficacy ENG-E2 vaginal ring woman 18 35 year age base number in-treatment pregnancy express Pearl Index ( PI ) . The study also assess safety tolerability ENG-E2 vaginal ring . The levonorgestrel-ethinyl estradiol ( LNG-EE ) 150/30 μg combine oral contraceptive ( COC ) use active comparator .</brief_summary>
	<brief_title>Efficacy Safety Etonogestrel + 17β-Estradiol Vaginal Ring Levonorgestrel-Ethinyl Estradiol Combined Oral Contraceptive Adult Women Risk Pregnancy ( MK-8342B-062 )</brief_title>
	<detailed_description />
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Desogestrel</mesh_term>
	<mesh_term>Contraceptives , Oral</mesh_term>
	<mesh_term>Levonorgestrel</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Etonogestrel</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<mesh_term>Contraceptives , Oral , Combined</mesh_term>
	<criteria>Premenopausal female risk pregnancy seek contraception . Willing use hormonal contraceptive vaginal ring 13 treatment cycle , intend use form contraception . Body mass index ( BMI ) ≥18 &lt; 38 kg/m^2 . In good physical mental health , base upon medical judgment investigator . Willing adhere use vaginal ring require trial procedure . Cardiovascular risk disorder , include history venous thromboembolic [ VTE ] event , arterial thrombotic thromboembolic [ ATE ] event , transient ischemic attack , angina pectoris , claudication ; high risk VTE event due recent prolonged immobilization , plan surgery require prolonged immobilization , hereditary acquire predisposition elevate risk venous arterial thrombosis ; currently smoke us tobacco/nicotine contain product ≥35 year age ; uncontrolled severe hypertension ; history severe dyslipoproteinemia ; &lt; 35 year age history migraine aura focal neurological symptom ≥35 year age history migraine without aura focal neurologic symptom ; diabetes mellitus endorgan involvement &gt; 20 year duration ; multiple cardiovascular risk factor ≥35 year age , obesity , inadequately control hypertension , use tobacco/ nicotine product , inadequately control diabetes . Gastrointestinal disorder , include history pancreatitis associate severe hypertriglyceridemia ; clinically significant liver disease , include active viral hepatitis cirrhosis ; history malabsorptive bariatric surgery . Other medical disorder , include history malignancy ≤5 year prior sign inform consent except adequately treat basal cell squamous cell skin cancer situ cervical cancer ; disease may worsen hormonal treatment disturbance bile flow , systemic lupus erythematosus , pemphigoid gestationis idiopathic icterus previous pregnancy , middleear deafness , Sydenham chorea , porphyria ; know allergy/sensitivity contraindication investigational product excipients ; history drug alcohol abuse dependence . Recent , current , suspected pregnancy ; least 2 menstrual cycle complete two 28day cycle hormonal contraceptive follow recent pregnancy ; breastfeed . Gynecologic condition : gonorrhea , chlamydia , trichomonas symptomatic vaginitis/cervicitis ; abnormal cervical Pap test positive highrisk human papillomavirus ( HPV ) test screening document within 3 year screen ; currently use intrauterine device/intrauterine system ( IUD/IUS ) contraceptive implant ; within past 6 month undiagnosed ( unexplained ) abnormal vaginal bleeding abnormal vaginal bleeding expect recur trial ; stage 4 pelvic organ prolapse ( 1 cm beyond introitus ) less degree prolapse history difficulty retain tampon , vaginal ring , product within vagina . Has use investigational drug and/or participate clinical trial within past 8 week .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>